BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 34214313)

  • 1. Cost of illness of diabetes mellitus in Indonesia: a systematic review.
    Patty YFPP; Mufarrihah ; Nita Y
    J Basic Clin Physiol Pharmacol; 2021 Jun; 32(4):285-295. PubMed ID: 34214313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-of-illness studies of diabetes mellitus: a systematic review.
    Ng CS; Lee JY; Toh MP; Ko Y
    Diabetes Res Clin Pract; 2014 Aug; 105(2):151-63. PubMed ID: 24814877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost of diabetes mellitus in Africa: a systematic review of existing literature.
    Mutyambizi C; Pavlova M; Chola L; Hongoro C; Groot W
    Global Health; 2018 Jan; 14(1):3. PubMed ID: 29338746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review.
    Afroz A; Alramadan MJ; Hossain MN; Romero L; Alam K; Magliano DJ; Billah B
    BMC Health Serv Res; 2018 Dec; 18(1):972. PubMed ID: 30558591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current total economic burden of diabetes mellitus in the Netherlands.
    Peters ML; Huisman EL; Schoonen M; Wolffenbuttel BHR
    Neth J Med; 2017 Sep; 75(7):281-297. PubMed ID: 28956787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and socioeconomic burden of diabetes mellitus in South Korean adults: a population-based study using administrative data.
    Oh SH; Ku H; Park KS
    BMC Public Health; 2021 Mar; 21(1):548. PubMed ID: 33743612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tobacco Cost of Illness Studies: A Systematic Review.
    Makate M; Whetton S; Tait RJ; Dey T; Scollo M; Banks E; Norman R; Pidd K; Roche AM; Allsop S
    Nicotine Tob Res; 2020 Apr; 22(4):458-465. PubMed ID: 30874290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Systematic Review of the Economic Burden of Type 2 Diabetes in Malaysia.
    Ganasegeran K; Hor CP; Jamil MFA; Loh HC; Noor JM; Hamid NA; Suppiah PD; Abdul Manaf MR; Ch'ng ASH; Looi I
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Systematic Review of the Economic Burden of Diabetes in Eastern Mediterranean Region Countries.
    Arshad MS; Alqahtani F; Rasool MF
    Diabetes Metab Syndr Obes; 2024; 17():479-487. PubMed ID: 38318449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The estimated healthcare cost of diabetic retinopathy in Indonesia and its projection for 2025.
    Sasongko MB; Wardhana FS; Febryanto GA; Agni AN; Supanji S; Indrayanti SR; Widayanti TW; Widyaputri F; Widhasari IA; Lestari YD; Adriono GA; Sovani I; Kartasasmita AS
    Br J Ophthalmol; 2020 Apr; 104(4):487-492. PubMed ID: 31285276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic burden of diabetic patients in India: A review.
    Bansode B; Jungari DS
    Diabetes Metab Syndr; 2019; 13(4):2469-2472. PubMed ID: 31405662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Projection of Diabetes Population Size and Associated Economic Burden through 2030 in Iran: Evidence from Micro-Simulation Markov Model and Bayesian Meta-Analysis.
    Javanbakht M; Mashayekhi A; Baradaran HR; Haghdoost A; Afshin A
    PLoS One; 2015; 10(7):e0132505. PubMed ID: 26200913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The direct and indirect cost of diabetes in Italy: a prevalence probabilistic approach.
    Marcellusi A; Viti R; Mecozzi A; Mennini FS
    Eur J Health Econ; 2016 Mar; 17(2):139-47. PubMed ID: 25427540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-of-illness studies in diabetes mellitus.
    Ettaro L; Songer TJ; Zhang P; Engelgau MM
    Pharmacoeconomics; 2004; 22(3):149-64. PubMed ID: 14871163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cost of diabetes in Latin America and the Caribbean in 2015: Evidence for decision and policy makers.
    Barcelo A; Arredondo A; Gordillo-Tobar A; Segovia J; Qiang A
    J Glob Health; 2017 Dec; 7(2):020410. PubMed ID: 29163935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic cost of diabetes in the Eastern Mediterranean region countries: A meta-analysis.
    Ansari-Moghaddam A; Setoodehzadeh F; Khammarnia M; Adineh HA
    Diabetes Metab Syndr; 2020; 14(5):1101-1108. PubMed ID: 32653635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Indirect Cost Burden of Cancer Care in Canada: A Systematic Literature Review.
    Iragorri N; de Oliveira C; Fitzgerald N; Essue B
    Appl Health Econ Health Policy; 2021 May; 19(3):325-341. PubMed ID: 33368032
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.